These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25531304)

  • 1. Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1.
    Patterson VL; Zullo AJ; Koenig C; Stoessel S; Jo H; Liu X; Han J; Choi M; DeWan AT; Thomas JL; Kuan CY; Hoh J
    PLoS One; 2014; 9(12):e115789. PubMed ID: 25531304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.
    Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R
    Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and increased mitophagy.
    Cilenti L; Ambivero CT; Ward N; Alnemri ES; Germain D; Zervos AS
    Biochim Biophys Acta; 2014 Jul; 1843(7):1295-307. PubMed ID: 24709290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
    Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
    Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial serine protease Omi/HtrA2 accentuates brain ischemia/reperfusion injury in rats and oxidative stress injury in vitro by modulating mitochondrial stress proteins CHOP and ClpP and physically interacting with mitochondrial fusion protein OPA1.
    You H; Jin Y; Kang J; Mao Y; Su J; Sun L; Wang L; Meng H
    Bioengineered; 2020 Dec; 11(1):1058-1070. PubMed ID: 33016225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for the mitochondrial HTRA2/OMI protease in aging.
    Kang S; Fernandes-Alnemri T; Alnemri ES
    Autophagy; 2013 Mar; 9(3):420-1. PubMed ID: 23242108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.
    Martins LM; Morrison A; Klupsch K; Fedele V; Moisoi N; Teismann P; Abuin A; Grau E; Geppert M; Livi GP; Creasy CL; Martin A; Hargreaves I; Heales SJ; Okada H; Brandner S; Schulz JB; Mak T; Downward J
    Mol Cell Biol; 2004 Nov; 24(22):9848-62. PubMed ID: 15509788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration.
    Ding X; Patel M; Shen D; Herzlich AA; Cao X; Villasmil R; Klupsch K; Tuo J; Downward J; Chan CC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4957-66. PubMed ID: 19443712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.
    Mandel H; Saita S; Edvardson S; Jalas C; Shaag A; Goldsher D; Vlodavsky E; Langer T; Elpeleg O
    J Med Genet; 2016 Oct; 53(10):690-6. PubMed ID: 27208207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PARL and HtrA2 in striatal neuronal injury after transient global cerebral ischemia.
    Yoshioka H; Katsu M; Sakata H; Okami N; Wakai T; Kinouchi H; Chan PH
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1658-65. PubMed ID: 23921894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria.
    Korwitz A; Merkwirth C; Richter-Dennerlein R; Tröder SE; Sprenger HG; Quirós PM; López-Otín C; Rugarli EI; Langer T
    J Cell Biol; 2016 Jan; 212(2):157-66. PubMed ID: 26783299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteomic screen with Drosophila Opa1-like identifies Hsc70-5/Mortalin as a regulator of mitochondrial morphology and cellular homeostasis.
    Banerjee S; Chinthapalli B
    Int J Biochem Cell Biol; 2014 Sep; 54():36-48. PubMed ID: 24998521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.
    Moisoi N; Klupsch K; Fedele V; East P; Sharma S; Renton A; Plun-Favreau H; Edwards RE; Teismann P; Esposti MD; Morrison AD; Wood NW; Downward J; Martins LM
    Cell Death Differ; 2009 Mar; 16(3):449-64. PubMed ID: 19023330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
    Plun-Favreau H; Klupsch K; Moisoi N; Gandhi S; Kjaer S; Frith D; Harvey K; Deas E; Harvey RJ; McDonald N; Wood NW; Martins LM; Downward J
    Nat Cell Biol; 2007 Nov; 9(11):1243-52. PubMed ID: 17906618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
    Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
    Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.
    Maus F; Sakry D; Binamé F; Karram K; Rajalingam K; Watts C; Heywood R; Krüger R; Stegmüller J; Werner HB; Nave KA; Krämer-Albers EM; Trotter J
    PLoS One; 2015; 10(9):e0137311. PubMed ID: 26340347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HtrA2 deficiency causes mitochondrial uncoupling through the F₁F₀-ATP synthase and consequent ATP depletion.
    Plun-Favreau H; Burchell VS; Holmström KM; Yao Z; Deas E; Cain K; Fedele V; Moisoi N; Campanella M; Miguel Martins L; Wood NW; Gourine AV; Abramov AY
    Cell Death Dis; 2012 Jun; 3(6):e335. PubMed ID: 22739987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases.
    Goo HG; Rhim H; Kang S
    Curr Protein Pept Sci; 2017; 18(7):746-757. PubMed ID: 26965693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLF1 is a proapoptotic antagonist of HOP complex-mediated survival.
    Sun Y; Chao JR; Xu W; Pourpak A; Boyd K; Moshiach S; Qi GY; Fu A; Shao HR; Pounds S; Morris SW
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):719-727. PubMed ID: 28137643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy.
    Wang P; Hu Y; Yao D; Li Y
    Cell Physiol Biochem; 2018; 49(6):2163-2173. PubMed ID: 30286467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.